Lawrence E. Crane

Array ( [id] => 9016509 [patent_doc_number] => 20130231473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'OLIGONUCLEOTIDE LIGATION' [patent_app_type] => utility [patent_app_number] => 13/409929 [patent_app_country] => US [patent_app_date] => 2012-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14342 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13409929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8394420 [patent_doc_number] => 20120232260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'AMPHIPHILIC NUCLEOTIDE COCHLEATE COMPOSITIONS AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/370158 [patent_app_country] => US [patent_app_date] => 2012-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16896 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13370158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8516919 [patent_doc_number] => 20120316328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'SYNTHESIS OF PHOSPHITYLATED COMPOUNDS USING A QUATERNARY HETEROCYCLIC ACTIVATOR' [patent_app_type] => utility [patent_app_number] => 13/367558 [patent_app_country] => US [patent_app_date] => 2012-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5488 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13367558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8875835 [patent_doc_number] => 08470801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Myocardial perfusion imaging methods and compositions' [patent_app_type] => utility [patent_app_number] => 13/361775 [patent_app_country] => US [patent_app_date] => 2012-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 16513 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13361775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186517 [patent_doc_number] => 20120115805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'USE OF AT LEAST ONE NUCLEIC ACID TO INFLUENCE THE NATURAL PIGMENTATION PROCESS' [patent_app_type] => utility [patent_app_number] => 13/354565 [patent_app_country] => US [patent_app_date] => 2012-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9890 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115805.pdf [firstpage_image] =>[orig_patent_app_number] => 13354565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9490549 [patent_doc_number] => 20140140955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'SUBSTITUTED PURINE NUCLEOSIDES, PHOSPHOROAMIDATE AND PHOSPHORODIAMIDATE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/988354 [patent_app_country] => US [patent_app_date] => 2011-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29703 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8302166 [patent_doc_number] => 20120184724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'PROTECTED MONOMERS AND METHODS OF DEPROTECTION FOR RNA SYNTHESIS' [patent_app_type] => utility [patent_app_number] => 13/339082 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 40060 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9122341 [patent_doc_number] => 20130289263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'COMPOUND, NUCLEIC ACID, METHOD FOR PRODUCING NUCLEIC ACID, AND KIT FOR PRODUCING NUCLEIC ACID' [patent_app_type] => utility [patent_app_number] => 13/997700 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12679 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13997700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9009585 [patent_doc_number] => 08524883 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide' [patent_app_type] => utility [patent_app_number] => 13/333872 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6508 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13333872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312515 [patent_doc_number] => 20120189538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'USE OF A2A ADENOSINE RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/333789 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3776 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13333789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347960 [patent_doc_number] => 20120208886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'Moisture Resistant Container Systems for Rapidly Bioavailable Dosage Forms' [patent_app_type] => utility [patent_app_number] => 13/331324 [patent_app_country] => US [patent_app_date] => 2011-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7100 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13331324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10192972 [patent_doc_number] => 09221868 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-29 [patent_title] => 'Uridine di- or tri-phosphate derivatives and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/990491 [patent_app_country] => US [patent_app_date] => 2011-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 16381 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8173612 [patent_doc_number] => 20120108531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'PHOSPHONATE NUCLEOSIDES USEFUL AS ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS, AND INTERMEDIATES FOR THEIR PRODUCTION' [patent_app_type] => utility [patent_app_number] => 13/291781 [patent_app_country] => US [patent_app_date] => 2011-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 34591 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108531.pdf [firstpage_image] =>[orig_patent_app_number] => 13291781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094107 [patent_doc_number] => 20120082645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => '2\'-C-METHYL-RIBOFURANOSYL CYTIDINE PRODRUGS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/289685 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 34969 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082645.pdf [firstpage_image] =>[orig_patent_app_number] => 13289685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8690175 [patent_doc_number] => 08389703 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-03-05 [patent_title] => 'Ribonucleoside analogs with novel hydrogen bonding patterns' [patent_app_type] => utility [patent_app_number] => 13/287169 [patent_app_country] => US [patent_app_date] => 2011-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9127 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13287169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784901 [patent_doc_number] => 20120046457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'PREPARATION OF DECITABINE' [patent_app_type] => utility [patent_app_number] => 13/282921 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9286 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046457.pdf [firstpage_image] =>[orig_patent_app_number] => 13282921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10870323 [patent_doc_number] => 08895520 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Method for treating a human patent suffering from Myeloid Neoplasias using 5-aminoimidazole-4-carboxamide' [patent_app_type] => utility [patent_app_number] => 13/281827 [patent_app_country] => US [patent_app_date] => 2011-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 3170 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13281827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8976594 [patent_doc_number] => 20130210024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'COMBINATION TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/879494 [patent_app_country] => US [patent_app_date] => 2011-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13629 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9174985 [patent_doc_number] => 20130316970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'NUCLEOTIDE ANALOGUE, METHOD OF SYNTHESIS OF NUCLEOTIDE ANALOGUE, USE OF NUCLEOTIDE ANALOGUE, ANTIVIRAL PRO-NUCLEOTIDE, PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/879709 [patent_app_country] => US [patent_app_date] => 2011-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5154 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9192246 [patent_doc_number] => 20130331561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'Method of Preparation of Antiviral Compounds and Useful Intermediates Thereof' [patent_app_type] => utility [patent_app_number] => 13/878303 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13744 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13878303 [rel_patent_id] =>[rel_patent_doc_number] =>)